Clinical Trials Directory

Trials / Unknown

UnknownNCT05434208

Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)

Effects of Nurse-led Telephone Based Service for Early Palliative Care Patients With Advanced Cancer: the Paltel Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Non-pharmacological, interventional, two-arm, randomized controlled trial. Early Palliative Care cancer patients will be randomized to active telephonic follow-up program by specialist nurses until end-of-treatment (28 days) (group A, research arm) or face-to-face visit at end of treatment (28 days) (group B, control arm). There are few studies demonstrating the efficacy of nurse-led telephone service in advanced cancer patients but it's still quite unclear how they can affect quality of life, symptom burden and caregivers distress. In addition, the ideal structure, method and timing of telephone follow-up as well are often not considered and have not been articulated. Nurse-led management by phone to advanced cancer patients could, for some patients, dramatically improve their care experience, quality of life and symptoms control. Investigators want to build an effective and sustainable approach for implementing the telephone service providing nurse-led telephone-based support to Early Palliative Care cancer patients. The aim is to investigate the feasibility of a proactive approach and measure the efficacy in terms of symptom management, satisfaction with care and impact on health care resources.

Conditions

Interventions

TypeNameDescription
OTHERNurse-led telephonic callsactive telephonic follow-up program by specialist nurses until end-of-treatment (28 days)

Timeline

Start date
2022-09-01
Primary completion
2024-12-01
Completion
2025-09-01
First posted
2022-06-27
Last updated
2022-06-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05434208. Inclusion in this directory is not an endorsement.